Antibiotic development pipeline runs dry. New drugs to fight resistant organisms are not being developed, experts say.
Nelson
Roxanne
R
D000900:Anti-Bacterial Agents / Q000191:economics; D035843:Biomedical Research / Q000639:trends; D003141:Communicable Diseases / Q000188:drug therapy*; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D004352:Drug Resistance, Microbial; D006801:Humans; D008829:Microbiology / Q000639:trends; D014481:United States
D000900:Anti-Bacterial Agents